Miromatrix Medical Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Miromatrix Medical's estimated annual revenue is currently $13.8M per year.(i)
  • Miromatrix Medical's estimated revenue per employee is $155,000

Employee Data

  • Miromatrix Medical has 89 Employees.(i)
  • Miromatrix Medical grew their employee count by -5% last year.

Miromatrix Medical's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
ControllerReveal Email/Phone
3
VP Clinical and Regulatory AffairsReveal Email/Phone
4
VP People and CultureReveal Email/Phone
5
Director Liver DevelopmentReveal Email/Phone
6
Associate Director Regulatory AffairsReveal Email/Phone
7
Director Organ Procurement and OPO EngagementReveal Email/Phone
8
Sr. Director QualityReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
R&D Manager at Miromatrix MedicalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M509%N/AN/A
#2
$7.4M48-35%N/AN/A
#3
$0.9M620%N/AN/A
#4
$0.3M2-91%N/AN/A
#5
$3.6M235%N/AN/A
#6
$0.9M6-33%N/AN/A
#7
$5M323%N/AN/A
#8
$14.7M959%N/AN/A
#9
$14.7M950%$20.5MN/A
#10
$27.9M14413%$39.1MN/A
Add Company

What Is Miromatrix Medical?

Miromatrix is a biotechnology company engaged in the development of fully biological human organs to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization/recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care.

keywords:N/A

N/A

Total Funding

89

Number of Employees

$13.8M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Miromatrix Medical News

2022-04-17 - Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene ...

EDEN PRAIRIE, Minn., April 19, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel...

2022-04-06 - Miromatrix Medical Inc. (NASDAQ:MIRO) Short Interest Update

Miromatrix Medical Inc engages in the development of biological human organs to solve the chronic shortage of transplantable organs. The company...

2022-03-30 - Miromatrix Reports Fourth Quarter and Full Year 2021 Results ...

EDEN PRAIRIE, Minn., March 30, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.8M890%$9M
#2
$30.6M9424%N/A
#3
$13.6M941%N/A
#4
$35M94-2%N/A
#5
$25.4M94-18%N/A